341 related articles for article (PubMed ID: 19241845)
21. [Prognostic significance of some markers in cutaneous melanoma treated with different therapeutic modalities].
Nepomniashchaia EM; Gusareva MA; Petrov SV
Vopr Onkol; 2008; 54(6):744-8. PubMed ID: 19241851
[TBL] [Abstract][Full Text] [Related]
22. Open study of the efficacy and mechanism of action of topical imiquimod in basal cell carcinoma.
Vidal D; Matías-Guiu X; Alomar A
Clin Exp Dermatol; 2004 Sep; 29(5):518-25. PubMed ID: 15347339
[TBL] [Abstract][Full Text] [Related]
23. Divergence between the high rate of p53 mutations in skin carcinomas and the low prevalence of anti-p53 antibodies.
Moch C; Moysan A; Lubin R; de la Salmonière P; Soufir N; Galisson F; Vilmer C; Venutolo E; Le Pelletier F; Janin A; Basset-Séguin N
Br J Cancer; 2001 Dec; 85(12):1883-6. PubMed ID: 11747330
[TBL] [Abstract][Full Text] [Related]
24. [Proliferative activity of basal cell and metatypical cell carcinoma of the skin].
Kazantseva IA; Khlebnikova AN; Babaev VR; Fager G
Arkh Patol; 1994; 56(4):35-8. PubMed ID: 7848103
[TBL] [Abstract][Full Text] [Related]
25. Expression of apoptotic and cell proliferation regulatory proteins in keratoacanthomas and squamous cell carcinomas of the skin.
Ribeiro D; Narikawa S; Marques ME
Pathol Res Pract; 2008; 204(2):97-104. PubMed ID: 18079070
[TBL] [Abstract][Full Text] [Related]
26. [Ki-67 and p53 expression as prognosticators of clinical course aggressiveness of squamous cell cancer of the larynx].
Gorban' NA; Ten VP; Pankratov VA
Vopr Onkol; 2007; 53(6):668-73. PubMed ID: 18416135
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical detection of EGFR, p185(erbB-2), Bcl-2 and p53 in breast carcinomas in pre-menopausal and post-menopausal women.
Talley L; Chhieng DC; Bell WC; Grizzle WE; Frost AR
Biotech Histochem; 2008 Feb; 83(1):5-14. PubMed ID: 18568671
[TBL] [Abstract][Full Text] [Related]
28. Pseudocarcinomatous hyperplasia with follicular differentiation overlying basal cell carcinoma.
Tuttle MS; Rosenberg AS; Winfield HL; Somach SC
Am J Dermatopathol; 2009 Aug; 31(6):557-60. PubMed ID: 19590419
[TBL] [Abstract][Full Text] [Related]
29. [Immunohistochemical study of p53 and Ki-67 in inverted papillomas and nasal polyps arising from nasal or paranasal regions].
Ikegawa K; Matsukuma S
Rinsho Byori; 2005 Jun; 53(6):499-503. PubMed ID: 16026075
[TBL] [Abstract][Full Text] [Related]
30. Calcifications associated with basal cell carcinoma: prevalence, characteristics, and correlations.
Slodkowska EA; Cribier B; Peltre B; Jones DM; Carlson JA
Am J Dermatopathol; 2010 Aug; 32(6):557-64. PubMed ID: 20489568
[TBL] [Abstract][Full Text] [Related]
31. CD10 expression in trichoepithelioma and basal cell carcinoma.
Pham TT; Selim MA; Burchette JL; Madden J; Turner J; Herman C
J Cutan Pathol; 2006 Feb; 33(2):123-8. PubMed ID: 16420307
[TBL] [Abstract][Full Text] [Related]
32. Epidermoid carcinoma of the lip: an immunohistochemical study.
García-Montesinos-Perea B; Val-Bernal JF; Saiz-Bustillo R
Med Oral Patol Oral Cir Bucal; 2005; 10(5):454-61. PubMed ID: 16264381
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical nuclear staining for p53, PCNA, and Ki-67 in different histologic variants of basal cell carcinoma.
Barrett TL; Smith KJ; Hodge JJ; Butler R; Hall FW; Skelton HG
J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):430-7. PubMed ID: 9308559
[TBL] [Abstract][Full Text] [Related]
34. Expression of p75 neurotrophin receptor in desmoplastic trichoepithelioma, infiltrative basal cell carcinoma, and microcystic adnexal carcinoma.
Jedrych J; McNiff JM
Am J Dermatopathol; 2013 May; 35(3):308-15. PubMed ID: 23598854
[TBL] [Abstract][Full Text] [Related]
35. Keloidal basal cell carcinoma: not a distinctive clinicopathological entity.
Jones M; Bresch M; Alvarez D; Böer A
Br J Dermatol; 2009 Jan; 160(1):127-31. PubMed ID: 18795924
[TBL] [Abstract][Full Text] [Related]
36. Metastatic basal cell carcinoma: four case reports, review of literature, and immunohistochemical evaluation.
Ionescu DN; Arida M; Jukic DM
Arch Pathol Lab Med; 2006 Jan; 130(1):45-51. PubMed ID: 16390237
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical FHIT expression still exists in early lesions of basal cell carcinoma.
Kiyici H; Bilezikçi B; Ozen O; Demirhan B
Pathol Res Pract; 2010 Jul; 206(7):445-9. PubMed ID: 20399571
[TBL] [Abstract][Full Text] [Related]
38. Pure versus combined Merkel cell carcinomas: immunohistochemical evaluation of cellular proteins (p53, Bcl-2, and c-kit) reveals significant overexpression of p53 in combined tumors.
Lai JH; Fleming KE; Ly TY; Pasternak S; Godlewski M; Doucette S; Walsh NM
Hum Pathol; 2015 Sep; 46(9):1290-6. PubMed ID: 26099430
[TBL] [Abstract][Full Text] [Related]
39. Bcl-2 and CD10 expression in the differential diagnosis of trichoblastoma, basal cell carcinoma, and basal cell carcinoma with follicular differentiation.
Córdoba A; Guerrero D; Larrinaga B; Iglesias ME; Arrechea MA; Yanguas JI
Int J Dermatol; 2009 Jul; 48(7):713-7. PubMed ID: 19570076
[TBL] [Abstract][Full Text] [Related]
40. Expression of cytokeratin 8 in basal cell carcinoma: a comparative immunohistochemical and immunoelectron microscopy study.
Kooy AJ; Tank B; de Jong TA; Vuzevski VD; Bosman FT; van Joost T
Anticancer Res; 1996; 16(1):277-82. PubMed ID: 8615621
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]